Insulinomas

Textbook of Endocrine Surgery

Volumn , Issue , 2005, Pages 715-729

  Wayne, Jeffrey D ^a,b   Kaplan, Edwin L ^c,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250819079     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0139-7.50083-1     Document Type: Chapter

References (54)

1. Nichols AG Simple adenoma of the pancreas arising from an island of Langerhans. J Med Res 1902, 8:385.
2. Banting FG, Best CH Internal secretion of the pancreas. J Lab Med 1922, 7:251.
3. Harris S Hyperinsulinism and dysinsulinism. JAMA 1924, 83:729.
4. Wilder RM, Allan FN, Power MH, et al. Carcinoma of the islets of the pancreas: Hyperinsulinism and hypoglycemia. JAMA 1927, 89:348.
5. Howland G, Campbell WR, Maltby EJ, et al. Dysinsulinism: Convulsions and coma due to islet cell tumor of the pancreas with operation and cure. JAMA 1929, 93:674.
6. Whipple AO, Frantz VK Adenomas of the islet cells with hyperinsulinism: A review. Ann Surg 1935, 101:1299.
7. Pearse AGE Common cytochemical and ultrastructural characteristics of cells producing polypeptide hormones (the APUD series) and their relevance to ultimobranchial C cells and calcitonin. Proc R Soc Lond B Biol Sci 1968, 170:71.
8. Marx S, Spiegel AM, Skarulis MC, et al. Multiple endocrine neoplasia type 1: Clinical and genetic topics. Ann Intern Med 1998, 129:484.
9. Zeiger MA, Norton JA Gs alpha-Identification of a gene highly expressed in insulinoma and other endocrine tumors. Surgery 1993, 114:458.
10. Rubenstein AH, Kuzuya H, Horowitz DL Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycemia disorders. Arch Intern Med 1977, 137(5):625.
11. Stefanini P, Carboni M, Petrassi N Surgical treatment of and prognosis of insulinoma. Clin Gastroenterol 1974, 3:697.
12. Boden G Insulinoma and glucagonoma. Semin Oncol 1987, 14:253.
13. Jaspan JB, Polonsky KS, Foster DW, et al. Clinical features and diagnosis of islet-cell tumors. Tumors of the Pancreas 1980, 469. Williams & Wilkins, Baltimore. A.R. Moosa (Ed.).
14. Merimee TJ, Tyson JE Hypoglycemia in man: Pathological and physiologic variants. Diabetes 1977, 26:161.
15. Gutman RA, Lazarus NR, Penhos JC, et al. Circulating proinsulin-like material in patients with functioning insulinomas. N Engl J Med 1971, 284:1003.
16. Service FJ, Natt N The prolonged fast. J Clin Endocrinol Metab 2000, 85:3973.
17. Kaplan EL, Rubenstein AH, Evans R, et al. Calcium infusion: A new provocative test for insulinomas. Ann Surg 1979, 190:501.
18. Brunt LM, Veldhius JD, Dilley WG, et al. Stimulation of insulin secretion by a rapid intravenous calcium infusion in patients with B-cell neoplasms of the pancreas. J Clin Endocrinol Metab 1986, 62:210.
19. Doppman JL, Chang R, Fraker DL, et al. Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med 1995, 123:269.
20. Kaplan EL Insulinoma-Surgical and diagnostic approach. Common Problems in Endocrine Surgery 1988, 272. Year Book Medical, Chicago. J.A. van Heerden (Ed.).
21. Sheppard BC, Norton JA, Doppman JL, et al. Management of islet cell tumors in patients with multiple endocrine neoplasia: A prospective study. Surgery 1989, 106:1108.
22. Doherty GM, Doppman JL, Shawker TH, et al. Results of a prospective strategy to diagnose, localize and resect insulinoma. Surgery 1991, 110:989.
23. Bottger TC, Junginger T Is preoperative radiographic localization of islet cell tumors in patients with insulinoma necessary?. World J Surg 1993, 17:427.
24. Semelka RC, Cumming MJ, Shoenut JP, et al. Islet cell tumors: Comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. Radiology 1993, 186:799.
25. Pavone P, Mitchell DG, Leonetti F, et al. Pancreatic beta cell tumors: MRI. J Comput Assist Tomogr 1993, 17:403.
26. Imamura M, Takahashi K Use of selective arterial secretin injection test to guide surgery in patients with Zollinger-Ellison syndrome. World J Surg 1993, 17:433.
27. Doppman JL, Miller DL, Chang R, et al. Intraarterial calcium stimulation test for detection of insulinomas. World J Surg 1993, 17:439.
28. Defreyne L, Moser C, Scheidt T, et al. Intraarterial calcium provocation for the preoperative diagnosis of the location of an occult insulinoma. Dtsch Med Wochenschr 1992, 117:1829.
29. Lo CY, Chan FL, Tam SC, et al. Value of intraarterial calcium stimulated venous sampling for regionalization of pancreatic insulinomas. Surgery 2000, 128:903.
30. Brown CK, Bartlett DL, Doppman JL, et al. Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas. Surgery 1997, 122:1193.
31. 123I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993, 20:716.
32. Van Eyck CHJ, Bruining HA, Reubi J-C, et al. Use of isotope-labeled somatostatin analogs for visualization of islet cell tumors. World J Surg 1993, 17:444.
33. Rosiere A, Ernst YJ, Roelants V, et al. Intraoperative gamma probe detection of insulinoma in an elderly patient with pancreatic cystic lesions. Clin Endocrinol (Oxf) 2002, 57:547.
34. Virgolini I, Raderer M, Kurtaran A, et al. Vasoactive intestinal peptide-receptor imaging for the localization and detection of intestinal adenocarcinomas and endocrine tumors. N Engl J Med 1994, 331:1116.
35. Ardengh JC, Rosenbaum P, Ganc AJ, et al. Role of EUS in the preoperative localization of insulinomas compared with spiral CT. Gastrointest Endosc 2000, 51:552.
36. Kirkeby H, Vilmann P, Burcharth F Insulinoma diagnosed by endoscopic ultrasonography-guided biopsy. J Laparoendosc Adv Surg Tech 1999, 9:295.
37. Bansal R, Tierney W, Carpenter S Cost effectiveness of EUS for preoperative localization of pancreatic tumors. Gastrointest Endosc 1999, 49:19.
38. Lane RJ, Coupland GAE Operative ultrasonic features of insulinomas. Am J Surg 1982, 144:585.
39. Norton JA, Sigel B, Baker AR, et al. Localization of an occult insulinoma by intraoperative ultrasonography. Surgery 1985, 97:381.
40. Boukhman MP, Karam JM, Shaver J, et al. Localization of insulinomas. Arch Surg 1999, 134:818.
41. Zeiger MA, Shawker TH, Norton JA Use of intraoperative ultrasonography to localize islet cell tumors. World J Surg 1993, 17:448.
42. Norton JA Intraoperative methods to stage and localize pancreatic and duodenal tumors. Ann Oncol 1999, 10(Suppl 4):182.
43. Grant CS, van Heerden J, Charboneau JW, et al. Insulinoma-The value of intraoperative ultrasonography. Arch Surg 1988, 123:843.
44. Proye C, Pattou F, Carnaille B, et al. Intraoperative insulin management during surgical management of insulinomas. World J Surg 1998, 22:1218.
45. Hirshberg B, Libutti SK, Alexander HR, et al. Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure. J Am Coll Surg 2002, 194:761.
46. Sussman LA, Christie R, Whittle DE Laparoscopic excision of distal pancreas including insulinoma. Aust NZ J Surg 1996, 66:414.
47. Fernandez-Cruz L, Saenz A, Astudillo E, et al. Outcome of laparoscopic pancreatic surgery: Endocrine and nonendocrine tumors. World J Surg 2002, 26:1057.
48. Edis AJ, McIllrath DC, van Heerdan JA, et al. Insulinoma: Current diagnosis and surgical management. Curr Probl Surg 1976, 13:1.
49. Rothmund M, Angelini L, Brunt LM, et al. Surgery of benign insulinoma: An international review. World J Surg 1990, 14:393.
50. Goode PN, Farndon JR, Anderson J Diazoxide in the management of patients with insulinoma. World J Surg 1986, 10:586.
51. Gill GV, Rauf O, MacFarlane IA Diaxoxide treatment for insulinoma: A national UK survey. Postgrad Med J 1997, 73:640.
52. Maton PN Use of octreotide acetate for the control of symptoms in patients with islet cell tumors. World J Surg 1993, 17:504.
53. Modlin IM, Lewis JJ, Ahlman H, et al. Management of unresectable malignant endocrine tumors of the pancreas. Surg Gynecol Obstet 1993, 176:507.
54. Scott A, Hinwood D, Donnelly R Radio-frequency ablation for symptom control in a patient with metastatic pancreatic insulinoma. Clin Endocrinol (Oxf) 2002, 56:557.